DIA Europe 2025
Visit Certara at Booth F2 in the DIA Europe 2025 in Basel, Switzerland | March 18-20, 2025
CoAuthor
Regulatory writing technology needs to be smarter, user-friendly, and collaborative—and CoAuthor delivers. It streamlines the process with fast template selection, structured content authoring, and generative AI within Microsoft Word.
- 275以上のeCTD準拠テンプレートにスタイルガイドを適用することで、文書のフォーマットに費やす時間を50%削減できます。
- 複合語から作用機序に関する段落まで、あらゆる文章をすべてのドキュメントで再利用できます。
- Leverage a biomedically-specialized GPT behind your firewall, for secure, prompt-based text generation
GlobalSubmit eCTD Platform
GlobalSubmit enables teams to manage the regulatory process so they can successfully publish, validate, and review eCTD submissions across a global footprint of regulatory health authorities.
- Create submissions that conform to any or all of 9 health authorities’ required structure, XML, and validation report.
- Review eCTD submissions across stakeholders prior to submitting
コンテンツ
From molecule to market, Certara is your trusted partner in the drug development journey. Backed by a team of experts and innovative technology, we’re here to guide and support you at every stage. Explore our expertly curated resources, and feel free to reach out with any questions.
-
Schedule a CoAuthor Demo: 薬事規制文書のための生成AIとライティングソフトウェア
-
Factsheet: CoAuthor | Factsheet
- White paper: Streamline Regulatory Writing with AI-Powered Solutions | Certara
-
Factsheet: 規制対応と薬事申請コンサルティング
-
White Paper: New EU Clinical Trial Regulation
- Factsheet: サターラ の戦略的早期開発ソリューション
-
On-demand webinar: GlobalSubmit Review and You: How to Expedite the Submission Review Process
-
Factsheet: GlobalSubmit eCTD Platform
-
Factsheet: Regulatory Operations | Certara
-
Factsheet: Strategic Regulatory Affairs | Certara